These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 519209)

  • 1. Genetic association with bladder cancer.
    Cartwright RA
    Br Med J; 1979 Sep; 2(6193):798. PubMed ID: 519209
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic association with bladder cancer.
    Wolf H
    Br Med J; 1979 Nov; 2(6201):1366. PubMed ID: 519454
    [No Abstract]   [Full Text] [Related]  

  • 3. Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk.
    Jiang DK; Ren WH; Yao L; Wang WZ; Peng B; Yu L
    Urology; 2010 Sep; 76(3):765.e1-7. PubMed ID: 20630574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.
    Gautam KA; Muktanand T; Sankhwar SN; Goel A; Sankhwar PL; Rajender S
    Cytokine; 2016 Jan; 77():152-6. PubMed ID: 26605964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary bladder cancer risk variants: recent findings and new challenges of GWAS and confirmatory studies.
    Selinski S
    Arch Toxicol; 2014 Jul; 88(7):1469-75. PubMed ID: 24912786
    [No Abstract]   [Full Text] [Related]  

  • 6. Hereditary bladder cancer.
    Kiemeney LA
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):110-5. PubMed ID: 18815925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association with bladder cancer.
    Br Med J; 1979 Sep; 2(6189):514. PubMed ID: 497668
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Jiang et al.: Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk (Urology 2010;76:765).
    Sergentanis TN; Economopoulos KP
    Urology; 2011 Jan; 77(1):259-60. PubMed ID: 21195855
    [No Abstract]   [Full Text] [Related]  

  • 9. Highlight report: N-acetyltransferase 2 and urinary bladder cancer risk.
    Blaszkewicz M
    Arch Toxicol; 2017 Sep; 91(9):3205-3206. PubMed ID: 28577040
    [No Abstract]   [Full Text] [Related]  

  • 10. Sex-specific familial risks of urinary bladder cancer and associated neoplasms in Sweden.
    Bermejo JL; Sundquist J; Hemminki K
    Int J Cancer; 2009 May; 124(9):2166-71. PubMed ID: 19117061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure.
    Golka K; Hermes M; Selinski S; Blaszkewicz M; Bolt HM; Roth G; Dietrich H; Prager HM; Ickstadt K; Hengstler JG
    Pharmacogenet Genomics; 2009 Nov; 19(11):903-6. PubMed ID: 19801959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer.
    Ryk C; Wiklund NP; Nyberg T; de Verdier PJ
    Nitric Oxide; 2011 Oct; 25(3):338-43. PubMed ID: 21703358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between MYC rs9642880[T] allele and bladder cancer risk: a meta-analysis.
    Zhao Y; Qi JG; Yang N; Lin YL; Liang J; Zhu X
    Genet Mol Res; 2015 Nov; 14(4):14745-51. PubMed ID: 26600535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XRCC3 T241M polymorphism and bladder cancer risk: a meta-analysis.
    Li F; Li C; Jiang Z; Ma N; Gao X
    Urology; 2011 Feb; 77(2):511.e1-5. PubMed ID: 20947146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c.29C>T polymorphism in the transforming growth factor-β1 (TGFB1) gene correlates with increased risk of urinary bladder cancer.
    Gautam KA; Pooja S; Sankhwar SN; Sankhwar PL; Goel A; Rajender S
    Cytokine; 2015 Oct; 75(2):344-8. PubMed ID: 26048435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphism and cancer susceptibility: evidence concerning acetyltransferases and cancer of the urinary bladder.
    Hein DW
    Bioessays; 1988 Dec; 9(6):200-4. PubMed ID: 3072000
    [No Abstract]   [Full Text] [Related]  

  • 17. Cumulative effect of genome-wide association study-identified genetic variants for bladder cancer.
    Wang M; Chu H; Lv Q; Wang L; Yuan L; Fu G; Tong N; Qin C; Yin C; Zhang Z; Xu J
    Int J Cancer; 2014 Dec; 135(11):2653-60. PubMed ID: 24740636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses.
    Sankhwar M; Sankhwar SN; Bansal SK; Gupta G; Rajender S
    Sci Rep; 2016 Jun; 6():27018. PubMed ID: 27246180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer.
    Selinski S; Blaszkewicz M; Ickstadt K; Gerullis H; Otto T; Roth E; Volkert F; Ovsiannikov D; Moormann O; Banfi G; Nyirady P; Vermeulen SH; Garcia-Closas M; Figueroa JD; Johnson A; Karagas MR; Kogevinas M; Malats N; Schwenn M; Silverman DT; Koutros S; Rothman N; Kiemeney LA; Hengstler JG; Golka K
    Carcinogenesis; 2017 Dec; 38(12):1167-1179. PubMed ID: 29028944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyltransferase 1 polymorphism and bladder cancer susceptibility: a meta-analysis of epidemiological studies.
    Wu K; Wang X; Xie Z; Liu Z; Lu Y
    J Int Med Res; 2013 Feb; 41(1):31-7. PubMed ID: 23569127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.